Randy Maloziec featured in Rare Disease Report article: "Fostamatinib Disodium Hexahydrate Tablet to Be Dispensed by US Bioservices for ITP"

Rigel Pharmaceuticals has recently selected US Bioservices to dispense fostamatinib disodium hexahydrate (TAVALISSE) tablets, for the treatment of adult patients with chronic immune thrombocytopenia (ITP), a rare blood disorder, who have had an insufficient response to a previous treatment.